Given that topical silencing of nociceptors is sufficient to substantially reduce systemic IgE production, silencing these neurons may have therapeutic potential for allergic/IgE-mediated diseases, including food and skin allergies, rhinitis, and asthma. This evidence concerns the gene IGHE and rhinitis.